百诚医药

301096 SZSE 证监会行业分类 M73研究和试验发展

Key Metrics

Market Cap

5.6B ($817.0M)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

802.0M

Net Income

-52.9M

Gross Margin

N/A

Op. Margin

-4.3%

Net Margin

-6.6%

ROE

-2.1%

ROA

-1.4%

D/E

0.44

Dividend Yield

N/A

EPS

-0.49

Current Ratio

2.01

Price History

Company Info

Industry	M73研究和试验发展
Market Segment	ChiNext
Currency	CNY
Fiscal Year	2024

Business Overview

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. operates as a pharmaceutical technology research and development and services company in China. The company primarily provides drug research and development services; and the transformation of research and development technology results for various pharmaceutical, as well as pharmaceutical research and development investment companies. Its business covers the principal links of drug discovery, pharmaceutical research, clinical trials, customized research and development and production, and registration applications. The company was incorporated in 20...

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 百诚医药

Ticker	301096
Exchange	SZSE
Sector	证监会行业分类
Industry	M73研究和试验发展